Organon (NYSE:OGN) will report earnings before market open on Monday. Last quarter, the company beat revenue expectations by 2.8%, with revenues of $1.59 billion. Analysts expect revenue to be flat at $1.57 billion this quarter, with adjusted earnings of $0.93 per share. Peers like Eli Lilly saw 53.9% revenue growth and Collegium Pharmaceutical reported a 31.4% increase. Organon shares are down 29.4% in the last month, with an average analyst price target of $10.83. Positive sentiment in branded pharmaceuticals has seen shares rise 3.9% on average. More details on Eli Lilly and Collegium Pharmaceutical results are available.

Read more at Barchart: Organon (OGN) Reports Earnings Tomorrow: What To Expect